Scientists reported that multiple myeloma (MM), an incurable hematological malignancy, could be specifically targeted by a monoclonal antibody that recognized a ubiquitously present protein, CD98 heavy chain.
[Science Translational Medicine]
Sorry, but the selected Zotpress account can't be found.